Find comprehensive market research and company reports on the hematology & oncology industry. More specifically, find reports on hematology instrumentation, sales strategies and disease management. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
All reports in Hematology & Oncology
|
The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
7/20/2012 | published by: Kalorama Information
... (IVD) testing in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests , is a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, ...
|
more...
|
$6,500.00
|
|
In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016
5/5/2012 | published by: MarketsandMarkets
... for about a half of the total market. The report studies various segments of the IVD market including Clinical Chemistry, Molecular diagnostics, Immunoassays, Hematology and Microbiology. Clinical chemistry dominates the global IVD market whereas molecular ...
|
more...
|
$4,650.00
|
|
2012 Global Occult Blood Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country
4/18/2012 | published by: Venture Planning Group
... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...
|
more...
|
$3,850.00
|
|
Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market
4/17/2012 | published by: Venture Planning Group
... and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? These and other key strategic issues facing decision-makers are explored in ...
|
more...
|
$4,850.00
|
|
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific ...
|
more...
|
$28,500.00
|
|
2012 World Cancer Diagnostic Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
4/17/2012 | published by: Venture Planning Group
... views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables
|
more...
|
$950.00
|
|
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$6,700.00
|
|
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
2012 US Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
4/17/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$8,700.00
|
|
Strategic Implications of Technological and Market Trends for the US Diagnostics Industry
4/17/2012 | published by: Venture Planning Group
... and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? These and other key strategic issues facing decision-makers are explored in ...
|
more...
|
$4,850.00
|
|
The 2012 Spanish Cancer Diagnostics Market
3/28/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
The 2012 UK Cancer Diagnostics Market
3/28/2012 | published by: Venture Planning Group
... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ...
|
more...
|
$5,400.00
|
|
The 2012 Hematology and Flow Cytometry Markets: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
3/28/2012 | published by: Venture Planning Group
The report identifies the major opportunities for hematology and flow cytometry instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers.
|
more...
|
$950.00
|
|
The 2012 Japanese Hematology and Flow Cytometry Markets
3/28/2012 | published by: Venture Planning Group
... trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 30 hematology and flow cytometry procedures performed in Japanese hospitals and commercial laboratories. Annual placements and ...
|
more...
|
$7,800.00
|
|
The 2012 Hematology and Flow Cytometry Markets: US, Europe, Japan Emerging Opportunities and Business Expansion Strategies
3/28/2012 | published by: Venture Planning Group
... in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of over 60 analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers. ...
|
more...
|
$28,400.00
|
|
The 2012 UK Hematology and Flow Cytometry Markets
3/28/2012 | published by: Venture Planning Group
... technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in UK hospitals and commercial laboratories. Annual placements and ...
|
more...
|
$5,500.00
|
|
The 2012 Italian Hematology and Flow Cytometry Markets
3/28/2012 | published by: Venture Planning Group
... technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in Italian hospitals and commercial laboratories. Annual placements and ...
|
more...
|
$5,500.00
|
|
The 2012 Hematology and Flow Cytometry Instrumentation Review: Operating Characteristics, Features and Selling PricesOf 60 High-, Medium-, and Low-Volume/POC Analyzers
3/28/2012 | published by: Venture Planning Group
This report reviews current instrumentation technologies, and compares features of over 60 leading hematology and flow cytometry analyzers.
|
more...
|
$1,850.00
|
|
The 2012 Spanish Hematology and Flow Cytometry Markets
3/28/2012 | published by: Venture Planning Group
... technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in Spanish hospitals, commercial laboratories and ambulatory care centers. ...
|
more...
|
$5,500.00
|
|
The 2012 Occult Blood Testing Market: US, Europe, JapanTest Volume and Sales Forecasts by Country
3/28/2012 | published by: Venture Planning Group
... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...
|
more...
|
$3,850.00
|
|
The 2012 Global Cancer Diagnostic Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country
3/28/2012 | published by: Venture Planning Group
... market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.
|
more...
|
$950.00
|
